Howard Bernstein
2021
In 2021, Howard Bernstein earned a total compensation of $1.3M as Interim Chief Executive Officer at SQZ Biotechnologies Co.
Compensation breakdown
| Non-Equity Incentive Plan | $148,732 |
|---|---|
| Option Awards | $799,713 |
| Salary | $391,400 |
| Other | $6,389 |
| Total | $1,346,234 |
Bernstein received $799.7K in option awards, accounting for 59% of the total pay in 2021.
Bernstein also received $148.7K in non-equity incentive plan, $391.4K in salary and $6.4K in other compensation.
Rankings
In 2021, Howard Bernstein's compensation ranked 7,683rd out of 12,415 executives tracked by ExecPay. In other words, Bernstein earned more than 38.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,683 out of 12,415 | 38th |
Division Manufacturing | 3,386 out of 5,505 | 39th |
Major group Chemicals And Allied Products | 1,498 out of 2,375 | 37th |
Industry group Drugs | 1,332 out of 2,096 | 37th |
Industry Biological Products, Except Diagnostic Substances | 304 out of 449 | 32nd |
Source: SEC filing on April 26, 2023.
Bernstein's colleagues
We found three more compensation records of executives who worked with Howard Bernstein at SQZ Biotechnologies Co in 2021.